PDS Biotechnology Corporation

Historical 13F Holders

Symbol
PDSB
CUSIP
70465T107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 70465T107 since 12/18/2024, newest first.

Filer % of Class Filed
Nant Capital, LLC 13D
19.9% 9/21/2026
Event 9/14/2026
Armistice Capital, LLC 13G/A Amendment 2
0% 11/14/2025
Event 9/30/2025
Armistice Capital, LLC 13G/A Amendment 1
5.7% 8/15/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G
10.0% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 226 k $170 k
2026 Q2 54 7.69 M $6.78 M
2026 Q1 43 5.05 M $3.05 M
2025 Q4 44 7.88 M $6.07 M
2025 Q3 50 5.62 M $6.64 M
2025 Q2 59 7.46 M $9.91 M
2025 Q1 53 8.24 M $9.81 M
2024 Q4 58 4.25 M $6.94 M
2024 Q3 65 4.34 M $16.6 M
2024 Q2 85 5.58 M $16.3 M
2024 Q1 82 7.78 M $30.8 M
2023 Q4 85 8.47 M $42.1 M
2023 Q3 84 7.86 M $39.7 M
2023 Q2 86 7.93 M $39.9 M
2023 Q1 74 7.68 M $49.8 M
2022 Q4 72 6.92 M $91.3 M
2022 Q3 53 5.18 M $15.4 M
2022 Q2 58 5.30 M $19.4 M
2022 Q1 59 5.85 M $36.2 M
2021 Q4 73 6.21 M $50.3 M
2021 Q3 66 6.75 M $101 M
2021 Q2 53 6.06 M $82.4 M
2021 Q1 33 3.15 M $14.3 M
2020 Q4 31 3.15 M $6.92 M
2020 Q3 32 3.30 M $7.68 M
2020 Q2 26 1.70 M $3.42 M
2020 Q1 30 1.64 M $1.19 M
2019 Q4 23 559 k $1.48 M
2019 Q3 22 509 k $1.72 M
2019 Q2 22 461 k $2.76 M
2019 Q1 19 287 k $2.12 M